Trimebutine CTB salt

CAS No. 1456509-46-8

Trimebutine CTB salt( —— )

Catalog No. M34266 CAS No. 1456509-46-8

Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
100MG 2403 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Trimebutine CTB salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.
  • Description
    Trimebutine CTB salt (GIC-1001) is an opioid receptor agonist used in the study of pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1456509-46-8
  • Formula Weight
    604.74
  • Molecular Formula
    C29H36N2O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCC(C=1C=CC=CC1)(N(C)C)CC)C2=CC(OC)=C(OC)C(OC)=C2.O=S(=O)(O)C=1C=CC=C(C1)C(=S)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Alvimopan monohydrat...

    A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus.

  • beta-Neoendorphin ac...

    beta-Neoendorphin acetate is an agonist of κ-opioid receptor

  • [Arg14,Lys15]Nocicep...

    Highly potent and selective NOP receptor agonist (EC50 = 1 nM). Displays > 875-fold selectivity over opioid receptors (IC50 values are 0.32, 280, > 10000 and 1500 for NOP, μ, δ and κ receptors respectively). Longer lasting and 30-fold more potent than nociceptin in vivo; pronociceptive and inhibits locomotor activity.